CN Stock MarketDetailed Quotes

600223 Lushang Freda Pharmaceutical

Watchlist
  • 5.92
  • -0.09-1.50%
Market Closed Sep 13 15:00 CST
6.02BMarket Cap25.08P/E (TTM)

Lushang Freda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lushang Freda Pharmaceutical Q2 2024 Earnings Date

Currency：CNYAug 24, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
1.03B
--
-13.85%
Net Income
--
83.14M
--
+3.37%
Analyst Rating
Strong Buy

Sep 15, 2024

Lushang Freda Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.109B--
--2024/FY-- / 4.370B--
Mar 22, 20242023/FY4.579B / 4.544B--
Mar 31, 20232022/FY12.951B / 12.040B--
--2021/FY12.363B / 15.184B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.109B--
--2024/FY-- / 4.370B--
Mar 22, 20242023/FY4.579B / 4.544B--
Mar 31, 20232022/FY12.951B / 12.040B--
--2021/FY12.363B / 15.184B--

Unlock Free Earnings Estimates

Lushang Freda Pharmaceutical Earnings Reports

  • Lushang Freda Pharmaceutical Co., Ltd. 2024 Interim Report

    Aug 23 12:00 ET

  • Summary of the semi-annual report of Lushang Freda Pharmaceutical Co., Ltd. in 2024

    Aug 23 12:00 ET

  • Lushang Freda Pharmaceutical Co., Ltd. Report for the first quarter of 2024

    Apr 29 12:00 ET

  • Lushang Freda Pharmaceutical Co., Ltd. 2023 Annual Report

    Mar 21 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 15, 2024

    Strong Buy

    • Strong Buy

      84.00%

    • Buy

      16.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data